Genomic Valley Biotech Ltd 21 Oct 2026 12:00 AM
Genomic Valley Biotech Limited to review financial results at October 30 board meeting,
Genomic Valley Biotech Limited will hold a board meeting on October 30, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company has also closed the trading window for directors, key managerial personnel, promoters, and designated persons from October 1, 2026, until 48 hours after the results are made public on October 30, 2026.
Genomic Valley Biotech Ltd 10 Oct 2026 12:00 AM
Genomic Valley Biotech submitted a regulatory certificate to BSE, processed by Beetal Financial,
Genomic Valley Biotech Limited, in a filing with the BSE Limited on October 10, 2026, confirmed submission of a certificate pertaining to Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026, with Beetal Financial & Computer Services Pvt Ltd handling the process.
Genomic Valley Biotech Ltd 31 Aug 2026 12:00 AM
Genomic Valley Biotech secures three-month AGM extension from Haryana’s Registrar of Companies,
Genomic Valley Biotech Limited informed the BSE Limited that the Registrar of Companies, Haryana, has approved an extension of three months for the company`s Annual General Meeting (AGM) for the financial year ended March 31, 2026, pushing the deadline from September 30, 2026, to December 31, 2026, citing health reasons of the promoter.
Genomic Valley Biotech Ltd 07 Aug 2026 12:00 AM
Genomic Valley Biotech schedules board meeting,
Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2026.
Genomic Valley Biotech Ltd 30 May 2026 12:00 AM
Genomic Valley Biotech reports standalone net loss of Rs 0.01 crore in the March 2026 quarter,
Net Loss of Genomic Valley Biotech reported to Rs 0.01 crore in the quarter ended March 2026 as against net loss of Rs 0.08 crore during the previous quarter ended March 2025. Sales declined 84.62% to Rs 0.04 crore in the quarter ended March 2026 as against Rs 0.26 crore during the previous quarter ended March 2025.For the full year,net profit declined 91.67% to Rs 0.03 crore in the year ended March 2026 as against Rs 0.36 crore during the previous year ended March 2025. Sales declined 67.86% to Rs 0.27 crore in the year ended March 2026 as against Rs 0.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.040.26 -85 0.270.84 -68 OPM %03.85 -14.8153.57 - PBDT00.01 -100 0.040.45 -91 PBT00.01 -100 0.040.45 -91 NP-0.01-0.08 88 0.030.36 -92 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now